Sources: Medical literature published in any language since 1966 on reboxet
ine, identified using AdisBase (a proprietary database of International, Au
ckland; New Zealand), Medline and EMBASE. Additional references were identi
fied from the reference lists of publish articles. Bibliograph cal informat
ion, including contributory unpublished data, was also requested from the c
ompany developing the drug.
Search strategy: AdisBase search terms were 'reboxetine', FCE-20124', 'rebo
xetine mesilate', 'reboxetine methanesulfonate' and 'Edronax'. Medline and
EMBASE search terms were 'reboxetine'. Searches were last updated 2 June 19
99.
Selection: Studies in patients with depression who received reboxetine. inc
lusion of studies was based mainly on the methods section of the trials. Wh
en available, large, well controlled trials with appropriate statistical me
thodology were preferred. Relevant pharmacodynamic and pharmacokinetic data
are also included.